Dantrolene, a ryanodine receptor stabilizer, is a candidate immunomodulator for treating rheumatic disease

被引：1
|
作者：
Nawata, T. [1 ,4 ]
Honda, T. [2 ]
Sakai, H. [2 ]
Tsuji, S. [2 ]
Otsuka, M. [2 ]
Uchinoumi, H. [1 ]
Kobayashi, S. [1 ]
Yamamoto, T. [3 ]
Asagiri, M. [2 ]
Yano, M. [1 ]
机构：
[1] Yamaguchi Univ, Dept Med & Clin Sci, Grad Sch Med, Ube, Japan
[2] Yamaguchi Univ, Dept Pharmacol, Grad Sch Med, Ube, Japan
[3] Yamaguchi Univ, Fac Hlth Sci, Grad Sch Med, Ube, Japan
[4] Yamaguchi Univ, Dept Med & Clin Sci, Grad Sch Med, 1-1-1 Minamikogushi, Ube 7558505, Japan
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2024年 / 53卷 / 03期
关键词：
D O I：
10.1080/03009742.2023.2297519
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：217 / 219
页数：3
相关论文
共 50 条
  • [21] Dantrolene stabilizes domain-domain interactions within the ryanodine receptor in failing hearts
    Kobayashi, S
    Yano, M
    Tateishi, H
    Mochizuki, M
    Noma, T
    Oda, T
    Tokuhisa, T
    Obayashi, M
    Yamamoto, T
    Matsuzaki, M
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : S324 - S324
  • [22] Stabilization of ryanodine receptor by dantrolene may be a potent therapeutic strategy against lethal arrhythmia
    Kobayashi, Shigeki
    Yano, Masafumi
    Xu, Xiaojuan
    Uchinoumi, Hitoshi
    Tateishi, Hiroki
    Mochizuki, Mamoru
    Yamamoto, Takeshi
    Matsuzaki, Masunori
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (08) : S163 - S163
  • [23] Dantrolene stabilizes domain-domain interactions within the ryanodine receptor in failing hearts
    Kobayashi, S
    Yano, M
    Tateishi, H
    Mochizuki, M
    Noma, T
    Oda, T
    Tokuhisa, T
    Obayashi, M
    Yamamoto, T
    Matsuzaki, M
    CIRCULATION, 2005, 112 (17) : U513 - U513
  • [24] Presence of Calmodulin Potentiates Block of Ryanodine Receptor Calcium Release Channels by Dantrolene and Flecainide
    Gomez-Hurtado, Nieves
    Oo, Ye Win
    Laver, Derek
    Knollmann, Bjorn
    CIRCULATION, 2014, 130
  • [25] Ryanodine receptor inhibition with acute dantrolene treatment reduces arrhythmia susceptibility in human hearts
    George, Sharon A.
    Brennan-McLean, Jaclyn A.
    Trampel, Katy A.
    Rytkin, Eric
    Faye, N. Rokhaya
    Knollmann, Bjorn C.
    Efimov, Igor R.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2023, 325 (04): : H720 - H728
  • [26] Dantrolene Induces Mitigation of Myocardial Ischemia-Reperfusion Injury by Ryanodine Receptor Inhibition
    Samiotis, Ilias
    Papakonstantinou, Nikolaos A.
    Dedeilias, Panagiotis
    Vasileiadis, Ioannis
    Papalois, Apostolos
    Deftereos, Spyridon
    Kotanidou, Anastasia
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2022, 34 (01) : 123 - 132
  • [27] Dantrolene stabilizes inter-domain interactions within domain switch of the ryanodine receptor
    Kobayashi, S
    Bannister, M
    Gangopadhyay, JP
    Hamada, T
    Parness, J
    Ikemoto, N
    BIOPHYSICAL JOURNAL, 2005, 88 (01) : 484A - 485A
  • [28] Ryanodine receptor inhibitor dantrolene reduces hypoxic-ischemic brain injury in neonatal mice
    Ovcjak, Andrea
    Xiao, Aijiao
    Kim, Ji-Sun
    Xu, Baofeng
    Szeto, Vivian
    Turlova, Ekaterina
    Abussaud, Ahmed
    Chen, Nai-hong
    Miller, Steven P.
    Sun, Hong-Shuo
    Feng, Zhong-Ping
    EXPERIMENTAL NEUROLOGY, 2022, 351
  • [29] Dantrolene inhibition of ryanodine receptor Ca2+ release channels -: Molecular mechanism and isoform selectivity
    Zhao, FY
    Li, P
    Chen, SRW
    Fruen, BR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) : 13810 - 13816
  • [30] The effects of dantrolene in the presence or absence of ryanodine receptor type 1 variants in individuals predisposed to malignant hyperthermia
    Noda, Yuko
    Mukaida, Keiko
    Miyoshi, Hirotsugu
    Nakamura, Ryuji
    Yasuda, Toshimichi
    Saeki, Noboru
    Nishino, Ichizo
    Tsutsumi, Yasuo M.
    ANAESTHESIA AND INTENSIVE CARE, 2022, 50 (04) : 312 - 319
12345